UnitedHealth, medical costs
Digest more
UnitedHealth Group's third quarter revenues grew 12% to $113.2 billion, but headwinds have created challenges for the company ...
UnitedHealth Group (NYSE: UNH) beat earnings expectations this morning, posting adjusted EPS of $2.92 against a consensus of ...
UnitedHealth Group Incorporated is rated Buy following solid Q3 earnings beat & signs of operational recovery. Learn more ...
UnitedHealth Group (NYSE: UNH) has outperformed the market over the past 15 years by 3.94% on an annualized basis producing an average annual return of 16.09%. Currently, UnitedHealth Group has a ...
UnitedHealth Optum sours on affiliated physician model and plans to reduce providers by 2026 to align with value-based care policies.
Q3 2025 Management View CEO Stephen Hemsley reported "introducing new leaders, strengthening underperforming businesses, ...
UnitedHealth Group (UNH) is at the center of investor attention as the company prepares to report third-quarter earnings on ...
UnitedHealth Group Inc. beat Wall Street expectations for third-quarter earnings and raised its outlook for the year, a sign ...
UnitedHealth has returned to better-than-expected growth after starting the year swamped by medical costs and withdrawing its ...
For the third quarter, UnitedHealth reported adjusted earnings per share of $2.92 compared with $7.15 a year earlier. Revenue ...
UnitedHealth Group expects its Medicare Advantage enrollment will shrink by 1 million people next year, as the insurer trims offerings across the country while focusing on higher profit margins as the ...
UnitedHealth Group (UNH) remains a solid Buy despite valuation risks. UNH remains the most expensive among peers. See more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback